Sawai Man Singh Medical College, Jaipur.
J Assoc Physicians India. 2022 Apr;70(4):11-12.
Non-Alcoholic Fatty Liver Disease is an emerging epidemic in the face of the new generation. It is considered the hepatic manifestation of the metabolic syndrome. With the increasing prevalence of obesity and metabolic syndrome, it has become a common sight in our outpatient department. We have investigated the echocardiographic parameters for systolic and diastolic dysfunction in the patients with NAFLD to evaluate its effects on the heart and hope our study could shine a light and provide us with a perspective into the various effects the metabolic syndrome has on our body.
We recruited 35 Normotensive, Non-Diabetic Non-Alcoholic Fatty Liver Disease Patients (NAFLD) of age ranging from 18 to 60 years of age diagnosed on the basis of ultrasound Abdomen and 35 Controls from both inpatient and outpatient department of Sawai Man Singh Medical College and Allied Hospitals from the month of August 2021 to October 2021 for the study. Every Patient underwent conventional transthoracic and Tissue Doppler Echocardiography along with their physical and metabolic parameters. All the patients of NAFLD were graded ultrasongraphically based on Hamaguchi et al criteria.
NAFLD patients had higher Body Mass Indices, Abdominal circumferences, Systolic Blood pressures, Total Cholesterol levels and Low-Density Lipoprotein levels in comparison to their normal counterparts. On the Echocardiographic front, the patient underwent transthoracic 2D ECHO and we observed an increased interventricular septum thickness (0.99 ± 0.04 vs 0.78 ± 0.05, p <0.0001), posterior wall thickness (0.96±0.05 vs 0.75±0.04 p < 0.0001) and left ventricular Mass (173±22.6 vs 116±8.24 p < 0.0001). On Tissue Doppler Imaging (TDI) we observed a decreased E/A ratio (1.25 ± 0.17 vs 1.44 ± 0.22 p < 0.0001) which was suggestive of an increased Left ventricular Dysfunction. On correlational analysis, we had made an observation that there was a positive correlation of the grading of fatty liver with that of interventricular septum thickness (r= 0.5305 p = 0.001), posterior wall thickness (r = 0.4362 p= 0.088) and left ventricular mass (r = 0.6292, p = 0.0001) with the grade of fatty liver.
From our study, it was imperative that NAFLD even in the absence of Hypertension or Diabetes has a role in the impairment of Systolic and Diastolic function of the left ventricle and its role in cardiovascular morbidity and mortality cannot be ignored.
研究非酒精性脂肪性肝病(NAFLD)患者的收缩和舒张功能障碍的超声心动图参数,以评估其对心脏的影响,并希望我们的研究能为代谢综合征对身体的各种影响提供一个视角。
我们招募了 35 名年龄在 18 至 60 岁之间的非高血压、非糖尿病的非酒精性脂肪性肝病患者(NAFLD),这些患者是根据腹部超声诊断的,另外还招募了 35 名来自 Sawai Man Singh 医学院附属医院的住院和门诊患者作为对照组。每位患者均接受常规经胸壁和组织多普勒超声心动图检查,并记录其身体和代谢参数。所有的 NAFLD 患者均根据 Hamaguchi 等标准进行超声分级。
与正常对照组相比,NAFLD 患者的体重指数、腹围、收缩压、总胆固醇水平和低密度脂蛋白水平均较高。在超声心动图方面,患者接受了经胸 2D ECHO 检查,我们观察到室间隔厚度(0.99 ± 0.04 比 0.78 ± 0.05,p < 0.0001)、后壁厚度(0.96±0.05 比 0.75±0.04,p < 0.0001)和左心室质量(173±22.6 比 116±8.24,p < 0.0001)增加。在组织多普勒成像(TDI)方面,我们观察到 E/A 比值降低(1.25 ± 0.17 比 1.44 ± 0.22,p < 0.0001),这表明左心室功能障碍增加。在相关分析中,我们发现脂肪肝的分级与室间隔厚度(r= 0.5305,p = 0.001)、后壁厚度(r = 0.4362,p = 0.088)和左心室质量(r = 0.6292,p = 0.0001)呈正相关。
即使在没有高血压或糖尿病的情况下,NAFLD 也会导致左心室收缩和舒张功能障碍,其在心血管发病率和死亡率中的作用不容忽视。